Griffiths et al., 1998 - Google Patents
Local and systemic responses against ricin toxin promoted by toxoid or peptide vaccines alone or in liposomal formulationsGriffiths et al., 1998
- Document ID
- 18078187365663668537
- Author
- Griffiths G
- Bailey S
- Hambrook J
- Keyte M
- Publication year
- Publication venue
- Vaccine
External Links
Snippet
The objective of this study was to develop a vaccine which would ultimately protect man from the lethal effects of inhaled ricin toxin. Porton rats have previously been protected from lethal quantities of inhaled ricin by subcutaneous (sc) ricin toxoid vaccine, but not without lung …
- 108010039491 Ricin 0 title abstract description 107
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48238—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48369—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying part being an antibody, an immunoglobulin, or a fragment thereof, e.g. a Fc-fragment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Griffiths et al. | Local and systemic responses against ricin toxin promoted by toxoid or peptide vaccines alone or in liposomal formulations | |
| AU2002214861B2 (en) | Vaccines with enhanced immune response and methods for their preparation | |
| JP4339598B2 (en) | Suppression of allergic reactions by transdermal administration of allergens with or conjugated to toxin subunits or fragments thereof | |
| Allison et al. | Liposomes as immunological adjuvants | |
| US5804566A (en) | Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides | |
| US6174872B1 (en) | Method for treating allergic lung disease | |
| US6849259B2 (en) | Polyclonal antibody composition for treating allergy | |
| Griffiths et al. | Comparison of the quality of protection elicited by toxoid and peptide liposomal vaccine formulations against ricin as assessed by markers of inflammation | |
| Rajananthanan et al. | Evaluation of novel aggregate structures as adjuvants: composition, toxicity studies and humoral responses | |
| AU2002214861A1 (en) | Vaccines with enhanced immune response and methods for their preparation | |
| CA2425740C (en) | Modulation of allergic response by injection into a lymph node | |
| Griffiths et al. | Liposomally-encapsulated ricin toxoid vaccine delivered intratracheally elicits a good immune response and protects against a lethal pulmonary dose of ricin toxin | |
| JP6122083B2 (en) | Nanoemulsion vaccine | |
| AU2001262067B2 (en) | Recombinant or purified polyclonal antibodies for treating allergy | |
| NO144056B (en) | DEVICE FOR ARTIFICIAL WATERING OF FLOWER BEDS, GARDENS ETC. | |
| IE912535A1 (en) | Liposomes that Provide Thymic Dependent Help to Weak Vaccine¹Antigens | |
| Ferro et al. | Immune responses to a GnRH-based anti-fertility immunogen, induced by different adjuvants and subsequent effect on vaccine efficacy | |
| US20030152581A1 (en) | Compound and method for the prevention and/or the treatment of allergy | |
| Yan et al. | Dependence of ricin toxoid vaccine efficacy on the structure of poly (lactide-co-glycolide) microparticle carriers | |
| DE69734392T2 (en) | VACCINATE AGAINST TUMORS OF B-LYMPHOCYTES | |
| Pali-Schöll et al. | Formulations for allergen immunotherapy in human and veterinary patients: new candidates on the horizon | |
| AT410636B (en) | METHOD FOR PRODUCING A VACCINE | |
| Mirchamsy et al. | Stimulating role of toxoids-laden liposomes in oral immunization against diphtheria and tetanus infections | |
| US20070003579A1 (en) | Allergen-specific immunotherapy | |
| Poulsen et al. | Improvement of specific immunotherapy by human IgG and modified allergens. |